Thyroid hormone (L-3,3 , ,5-triiodothyronine, T 3 ) is important for the normal function of most tissues, with major actions on O 2 consumption and metabolic rate. In the liver, these are due to (i) transcriptional activation of respiratory genes leading to increased reactive O 2 species generation in mitochondria and other subcellular sites; and (ii) enhancement in the respiratory burst activity in Kupffer cells (KC), with consequent antioxidant depletion. Under these conditions, the redox upregulation of KC-dependent expression of cytokines (tumor necrosis factor-, interleukin (IL)-1, IL-6) is achieved, thus triggering the expression of enzymes (inducible nitric oxide synthase, manganese superoxide dismutase), anti-apoptotic proteins (Bcl-2), acute phase proteins (haptoglobin, -fibrinogen), and hepatocyte proliferation. The above responses (i) represent adaptive mechanisms to re-establish redox homeostasis and promote cell survival; (ii) occur via nuclear factor-B, signal transducer and activator of transcription-3, and activator protein-1activation; and (iii) afford protection against ischemia-reperfusion liver injury. This strategy represents a novel preconditioning mechanism that has clinical potential either in preventing ischemia-reperfusion injury during liver surgery in man or in liver transplantation using reduced-size grafts from living donors.